ID | Description | Adjusted P values | Counts | Gene names |
---|---|---|---|---|
hsa05206 | MicroRNAs in cancer | 0.00000602 | 9 | MCL1/CDC25A/NOTCH2/BCL2L2/VEGFA/CDKN1A/KIF23/SOX4/TIMP3 |
hsa04110 | Cell cycle | 0.0000297 | 6 | CDC25A/WEE1/CHEK1/CDKN1A/E2F5/YWHAH |
hsa01522 | Endocrine resistance | 0.00011607 | 5 | NCOA3/CDKN1A/MAPK9/JAG1/NOTCH2 |
hsa04114 | Oocyte meiosis | 0.00027439 | 5 | PPP3R1/BTRC/ITPR1/YWHAH/CPEB3 |
hsa05200 | Pathways in cancer | 0.00056634 | 8 | RASGRP1/RUNX1T1/VEGFA/CDKN1A/GNB5/HIF1A/MAPK9/LAMC1 |
hsa04010 | MAPK signaling pathway | 0.00132625 | 6 | PPP3R1/RASGRP1/DUSP2/MAP3K1/MAPK9/MEF2C |
hsa05202 | Transcriptional misregulation in cancer | 0.00157405 | 5 | CDKN1A/RUNX1T1/MEF2C/HOXA10/PBX3 |
hsa05205 | Proteoglycans in cancer | 0.0029711 | 5 | CDKN1A/ITPR1/TIMP3/VEGFA/HIF1A |
hsa04115 | p53 signaling pathway | 0.00438531 | 3 | CDKN1A/CHEK1/RRM2 |
hsa04151 | PI3K-Akt signaling pathway | 0.00536491 | 6 | VEGFA/MCL1/CDKN1A/GNB5/YWHAH/LAMC1 |
hsa04921 | Oxytocin signaling pathway | 0.00681985 | 4 | CDKN1A/PPP3R1/ITPR1/MEF2C |
hsa05166 | HTLV-I infection | 0.00730939 | 5 | CDKN1A/PPP3R1/MAP3K1/CHEK1/TP53INP1 |
hsa04320 | Dorso-ventral axis formation | 0.00825292 | 2 | CPEB3/NOTCH2 |
hsa04710 | Circadian rhythm | 0.00935463 | 2 | BTRC/CRY2 |
hsa04912 | GnRH signaling pathway | 0.00943716 | 3 | MAP3K1/ITPR1/MAPK9 |
hsa04914 | Progesterone mediated oocyte maturation | 0.0108457 | 3 | MAPK9/CPEB3/CDC25A |
hsa04723 | Retrograde endocannabinoid signaling | 0.01205547 | 3 | ITPR1/MAPK9/GNB5 |
hsa04066 | HIF-1 signaling pathway | 0.01333979 | 3 | CDKN1A/HIF1A/VEGFA |
hsa04660 | T cell receptor signaling pathway | 0.01401011 | 3 | PPP3R1/RASGRP1/MAPK9 |
hsa05219 | Bladder cancer | 0.01648587 | 2 | CDKN1A/VEGFA |
hsa04724 | Glutamatergic synapse | 0.01688062 | 3 | PPP3R1/ITPR1/GNB5 |
hsa04919 | Thyroid hormone signaling pathway | 0.01923358 | 3 | NCOA3/HIF1A/NOTCH2 |
hsa04330 | Notch signaling pathway | 0.02190805 | 2 | JAG1/NOTCH2 |
hsa04728 | Dopaminergic synapse | 0.0226392 | 3 | ITPR1/MAPK9/GNB5 |
hsa04014 | Ras signaling pathway | 0.0227743 | 4 | RASGRP1/VEGFA/MAPK9/GNB5 |
hsa04380 | Osteoclast differentiation | 0.02445721 | 3 | PPP3R1/OSCAR/MAPK9 |
hsa04068 | FoxO signaling pathway | 0.02539501 | 3 | CDKN1A/GABARAPL1/MAPK9 |
hsa04210 | Apoptosis | 0.02882821 | 3 | MAPK9/ITPR1/MCL1 |
hsa04310 | Wnt signaling pathway | 0.02882821 | 3 | PPP3R1/BTRC/MAPK9 |
hsa05161 | Hepatitis B | 0.03195714 | 3 | CDKN1A/MAP3K1/MAPK9 |
hsa04370 | VEGF signaling pathway | 0.03660229 | 2 | PPP3R1/VEGFA |
hsa04924 | Renin secretion | 0.03660229 | 2 | PPP3R1/ITPR1 |
hsa05131 | Shigellosis | 0.03864514 | 2 | BTRC/MAPK9 |
hsa04720 | Long-term potentiation | 0.03864514 | 2 | PPP3R1/ITPR1 |
hsa05212 | Pancreatic cancer | 0.04073055 | 2 | VEGFA/MAPK9 |
hsa05211 | Renal cell carcinoma | 0.04178893 | 2 | HIF1A/VEGFA |
hsa04622 | RIG-I-like receptor signaling pathway | 0.0428576 | 2 | MAP3K1/MAPK9 |
hsa04141 | Protein processing in endoplasmic reticulum | 0.0429848 | 3 | MAPK9/TRAM1/PDIA6 |
hsa04022 | cGMP-PKG signaling pathway | 0.04681452 | 3 | PPP3R1/ITPR1/MEF2C |
hsa04260 | Cardiac muscle contraction | 0.04835144 | 2 | TPM2/SLC9A6 |